Patient Guide: A Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone and Together With a COVID-19 mRNA Vaccine in Adults Aged 50 Years and Above

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 24 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06374394
Status: ACTIVE_NOT_RECRUITING
Condition: Respiratory Syncytial Virus Infections
Phase: PHASE3

Where You Can Participate

This study is available at 24 locations across the country.

Top locations include:
  • • Coral Gables, Florida
  • • Savannah, Georgia
  • • Evansville, Indiana
  • • And 21 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone and Together With a COVID-19 mRNA Vaccine in Adults Aged 50 Years and Above - Join Clinical Trial NCTNCT06374394

How to Join This Clinical Trial - NCTNCT06374394

Learn how to participate in this PHASE3 trial studying an investigational therapy for Respiratory Syncytial Virus Infections. Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Respiratory Syncytial Virus Infections. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Respiratory Syncytial Virus Infections
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT06374394 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 24 locations. Find a study site near you:

Clinical Research Site

Coral Gables, Florida 33134 - United States

Status: Contact for availability

Clinical Research Site

Savannah, Georgia 31406 - United States

Status: Contact for availability

Clinical Research Site

Evansville, Indiana 47714 - United States

Status: Contact for availability

Clinical Research Site

Omaha, Nebraska 68134 - United States

Status: Contact for availability

Clinical Research Site

Rochester, New York 14609 - United States

Status: Contact for availability

Clinical Research Site

Winston-Salem, North Carolina 27103 - United States

Status: Contact for availability

Clinical Research Site

North Charleston, South Carolina 29405 - United States

Status: Contact for availability

Clinical Research Site

Newport News, Virginia 23606 - United States

Status: Contact for availability

Clinical Research Site

Antwerpen, 2000 - Belgium

Status: Contact for availability

Clinical Research Site

Edegem, 2650 - Belgium

Status: Contact for availability

And 14 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Respiratory Syncytial Virus Infections:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships